These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

841 related items for PubMed ID: 15465210

  • 1. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210
    [Abstract] [Full Text] [Related]

  • 2. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Anticancer Res; 2004 Nov 01; 24(5A):2975-83. PubMed ID: 15517904
    [Abstract] [Full Text] [Related]

  • 3. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S, Kasaoka S, Maruyama K, Nigg D, Sakurai Y, Nagata K, Suzuki M, Kinashi Y, Maruhashi A, Ono K.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1515-22. PubMed ID: 17126210
    [Abstract] [Full Text] [Related]

  • 4. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S, Kato I, Ono K, Masunaga S, Suzuki M, Nagata K, Sakurai Y, Yura Y.
    Oral Oncol; 2004 May 01; 40(5):474-82. PubMed ID: 15006618
    [Abstract] [Full Text] [Related]

  • 5. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
    Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M.
    Br J Radiol; 1997 Apr 01; 70(832):391-8. PubMed ID: 9166076
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
    Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Suzuki M.
    Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):828-39. PubMed ID: 11697329
    [Abstract] [Full Text] [Related]

  • 7. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF, Yang W, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH.
    Cancer Res; 1997 Mar 15; 57(6):1129-36. PubMed ID: 9067283
    [Abstract] [Full Text] [Related]

  • 8. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S, Nagasawa H, Uto Y, Hori H, Ohnishi K, Takahashi A, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Ono K.
    Oncol Rep; 2005 Aug 15; 14(2):393-400. PubMed ID: 16012721
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Gotoh K, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Radiat Med; 2006 Feb 15; 24(2):98-107. PubMed ID: 16715670
    [Abstract] [Full Text] [Related]

  • 10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI, Chung HP, Liu HM, Chi CW, Lui WY.
    Appl Radiat Isot; 2009 Jul 15; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M, Kinashi Y, Ono K.
    Anticancer Res; 2006 Jul 15; 26(2A):1261-70. PubMed ID: 16619533
    [Abstract] [Full Text] [Related]

  • 12. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Int J Hyperthermia; 2006 Jun 15; 22(4):287-99. PubMed ID: 16754350
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Jun 15; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 14. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):391-8. PubMed ID: 10760435
    [Abstract] [Full Text] [Related]

  • 15. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A, Obayashi S, Kato I, Ono K, Suzuki M, Nagata K, Sakurai Y, Yura Y.
    Int J Radiat Biol; 2006 Jan 01; 82(1):21-9. PubMed ID: 16546900
    [Abstract] [Full Text] [Related]

  • 16. Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.
    Masunaga S, Ono K, Sakurai Y, Takagaki M, Kobayashi T, Suzuki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1998 Jul 15; 41(5):1163-70. PubMed ID: 9719128
    [Abstract] [Full Text] [Related]

  • 17. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 2000 Feb 01; 46(3):653-9. PubMed ID: 10701745
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):996-1007. PubMed ID: 11572769
    [Abstract] [Full Text] [Related]

  • 19. Responses of total and quiescent cell populations in solid tumors to boron and gadolinium neutron capture reaction using neutrons with two different energy spectra.
    Masunaga S, Ono K, Sakurai Y, Suzuki M, Takagaki M, Kobayashi T, Kinashi Y, Akaboshi M.
    Jpn J Cancer Res; 1998 Jan 01; 89(1):81-8. PubMed ID: 9510480
    [Abstract] [Full Text] [Related]

  • 20. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K, Ishida O, Kasaoka S, Takizawa T, Utoguchi N, Shinohara A, Chiba M, Kobayashi H, Eriguchi M, Yanagie H.
    J Control Release; 2004 Aug 11; 98(2):195-207. PubMed ID: 15262412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.